Lyra Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update

/PRNewswire/ -- Lyra Therapeutics, Inc. (Nasdaq: LYRA)("Lyra" or the "Company"), a clinical-stage therapeutics company leveraging its proprietary XTreo™...

Related Keywords

Australia ,United States ,American ,Maria Palasis ,Richard Nieman ,Bristol Myers Squibb ,Linkedin ,Twitter ,Prnewswire Lyra Therapeutics Inc ,Nantahala Capital Management ,Lyra Therapeutics Inc ,American Rhinologic Society ,Nasdaq ,Chief Medical ,Chief Executive Officer ,Chief Medical Officer ,Medical Head ,Global Medical Officer ,Asia Pacific Medical ,Perceptive Advisors ,North Bridge Venture Partners ,Pura Vida Investments ,Venrock Healthcare Capital Partners ,Otolaryngology Spring Meetings ,American Rhinologic ,Lyra Therapeutics ,Nc ,